Increasing Prevalence of Chronic Diseases to Augment Growth of the Generic Sterile Injectable Market

Generic Sterile Injectable Market


 The generic sterile injectables are (Food and Drug Administration-approved) biologics that are used for the treatment of various drugs and have the same active ingredients as its branded versions. However, the inactive content of the drug may vary. The generic sterile injectables are widely used in majority of clinics and hospitals worldwide. However, these Injectables are very inexpensive compared to their branded counterparts.

Market Dynamics:

Increasing prevalence of chronic diseases, especially in North America, is expected to augment the growth of the generic sterile injectable market. According to the Centers for Disease Control and Prevention (CDC), chronic diseases such as diabetes, cancer, and heart disease are the leading causes of death and disability in the United States.

Moreover, the outbreak COVID-19 is expected to offer lucrative growth opportunities for players in the generic sterile injectable market. For instance, in January 2021, Civica planned to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia. Sterile injectables manufactured in this facility will used in hospitals for COVID-19 patient care, emergency room, and intensive-care units, surgeries, and to treat other serious conditions.

Furthermore, the rising investment in technically advanced sterile injectable pharmaceutical production facilities is expected to propel the generic sterile injectable market growth. For instance, in 2018, Pfizer planned to build (with US$ 465 million investment) one of the most technically advanced sterile injectable production facilities in Portage, Michigan.

However, stringent government regulations and the shortage of sterile injectables is expected to restrain the generic sterile injectable market growth. FDA has been paying increased attention to quality control, critical issue for injectable drugs.

Competitive Analysis:

Major players operating in the generic sterile injectable market are Merck & Co. Inc., AstraZeneca, Mylan, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries Ltd., Hikma, Teva Pharmaceuticals, Novartis/Sandoz, Pfizer/Hospira, Fresenius Kabi, and Baxter Inc.

Market players are adopting various inorganic strategies, such as merger and acquisition, product launch, etc., to strengthen their market position. For instance, in February 2021, Centrient Pharmaceuticals signed an agreement to acquire Astral SteriTech Private Limited to strengthen its position as the global business-to-business industry leader in beta-lactam antibiotics.

In October 2020, Leucadia Pharma announced the launch and availability of its FDA-approved generic Acetaminophen Injection, 1000 mg/100 mL (10 mg/mL).

In September 2020, Mylan shell out US$ 756 million for European rights to a suite of Aspen Pharmacare's sterile injectable anticoagulants.

Comments

Post a Comment

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Image
  Whiskey or single malt whiskey is simply a form of distilled beverage made by distilling alcohol from grain mash or even by blending both. Different grains are utilized for different types, such as corn, barley, rye, and wheat. In Scotland, they call their whiskey black tea, a lighter caramel scotch, Irish cream, and liqueur. Whichever form is utilized, the result is usually a flavorful and smooth drink that has a distinct taste, and many people prefer a whiskey with a lower alcohol content. For example, single malt whiskey is the least expensive. The highest price however is the least distilled; that is Bourbon whiskey. Bourbon whiskey is the most popular whiskey in America and in many other countries around the world. Its price range is very wide, starting from as low as about US$ 12 a bottle to over a hundred dollars. So the price definitely varies. Whichever class you belong to, there is always a whiskey that will suit your preference. Single malt scotch whiskey is made ...
Read more

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Image
  Viral Vectors are proteins that have been discovered to be essential for the spread of various viruses and infectious agents. These proteins can cause serious health risks if they are improperly introduced or if a wrong agent is used to fight them off. Viral vectors have often been used in various gene therapy procedures with the ultimate objective of curing various ailments in the biological fields of neurology, gene therapy, cancer, and metabolic disorder. Clinical studies regarding viral vectors remain one of the key factors in the manufacturing of viral vectors. Plasmids are used to deliver DNA contain genes for antibiotic resistance. In fact, scientists have developed many uses of plasmids and created software to record the DNA sequences of plasmids for applications in various techniques. Thus, such continuous R&D activities can potentially stimulate growth of the viral vectors and plasmid DNA manufacturing market . Recently, in April 2021, Oxford Biomedica plc entered...
Read more

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)

Image
  There are many reasons why people choose hard surface floors over other types of flooring. Hard surfaces offer a level of durability and are very aesthetically pleasing. Unfortunately, choosing this type of flooring can be confusing and costly. There are four main hard surface varieties namely vinyl plank, laminate, solid hardwood, and engineered wood. Each has their own style strengths and provide different advantages. Increasing population coupled with rapid urbanization is expected to drive growth of the global hard surface flooring market . According to the United Nations (UN), by 2050, around 68% of the global population is expected to live in urban areas, increasing from 55% in 2018. According to the same source, in 2018, around 4.2 billion people were living in urban areas, increasing from 751 million in 1950. Furthermore, according to the World Bank, in 2019, the global population reached 7.674 billion, increasing from 6.84 billion in 2009. As a result of this, building...
Read more